[ad_1] NEW YORK, Nov. 11, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. […]
Tag: P. A.
Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation
[ad_1] NEW YORK, Nov. 10, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting […]
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Nov. 10, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September […]
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Nov. 10, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of DexCom, Inc. (NASDAQ: […]
CPTN Investors Have Opportunity to Lead Cepton, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Nov. 10, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and […]
